Back to Search
ANCA BULGARU, MD
MD
Hematology & Oncology Physician
NPI: 1659356640IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
041587(CT)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
041587(CT)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1993
Research & Publications (6)
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors.
PMID 17693421·Ann Oncol·2007
8-other
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.
PMID 17195945·Invest New Drugs·2007
3-trial
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.
PMID 14581279·Ann Oncol·2003
3-trial
A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumors.
PMID 14519628·Clin Cancer Res·2003
3-trial
Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinase.
PMID 12820772·Expert Rev Anticancer Ther·2003
6-review
The BCL2-family of protein ligands as cancer drugs: the next generation of therapeutics.
PMID 12769779·Curr Med Chem Anticancer Agents·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 WASHINGTON ST, SUITE 220
NORWICH, CT 06360 - Phone
- (860) 886-8362
Quick Facts
- NPI
- 1659356640
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 6
Are you this provider?
Claim Your Profile